Published in Oncology Business Week, September 21st, 2008
"The completion of preclinical studies is a key milestone for our company, and means that we are now ready to prepare our first IND for Alzheimer's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.